Using genetics to explore whether the cholesterol-lowering drug ezetimibe may cause an increased risk of cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Using genetics to explore whether the cholesterol-lowering drug ezetimibe may cause an increased risk of cancer

Published:2017-06-30 Issue:6 Volume:46 Page:1777-1785
ISSN:0300-5771
Container-title:International Journal of Epidemiology
language:en
Short-container-title:

Author:

Kobberø Lauridsen Bo,Stender Stefan,Frikke-Schmidt Ruth,Nordestgaard Børge G,Tybjærg-Hansen Anne

Funder

Danish Medical Research Council

Publisher

Oxford University Press (OUP)

Subject

General Medicine,Epidemiology

Link

http://academic.oup.com/ije/article-pdf/46/6/1777/22325806/dyx096.pdf

Reference27 articles.

1. Simvastatin with or without ezetimibe in familial hypercholesterolemia;N Engl J Med,2008

2. Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial;J Am Coll Cardiol,2008

3. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial;Lancet,2011

4. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis;N Engl J Med,2008

5. Ezetimibe added to statin therapy after acute coronary syndromes;N Engl J Med,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid-lowering drugs and cancer: an updated perspective;Pharmacological Reports;2023-11-28

2. Promotion of colorectal cancer cell death by ezetimibe via mTOR signaling-dependent mitochondrial dysfunction;Frontiers in Pharmacology;2023-02-07

3. Ezetimibe and Cancer: Is There a Connection?;Frontiers in Pharmacology;2022-07-18

4. Impacts of ezetimibe on risks of various types of cancers: a meta-analysis and systematic review;European Journal of Cancer Prevention;2022-05-29

5. Role of Lipoproteins in the Pathophysiology of Breast Cancer;Membranes;2022-05-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3